Trials
Search / Trial NCT06418633

Variations in the Hemostatic System Induced by a Standardized Walking Test

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · May 13, 2024

Trial Information

Current as of February 12, 2025

Not yet recruiting

Keywords

Physical Exercise

ClinConnect Summary

Induced venous thromboembolism is a situation in which venous thromboembolic disease is triggered by an acute event that activates hemostasis: surgery, trauma, infectious or inflammatory outbreak, etc., a situation in which the risk of spontaneous recurrence, in the absence of a new provoking circumstance, is low, leading to the suggestion, not of long-term thromboprophylaxis, but simply the transient prevention of an event when there is a new clinical event likely to activate hemostasis. One such event is acute physical exertion.

Indeed, cohort studies seem to show that regular physical a...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Inclusion criteria common to both groups :
  • Patients who have given written informed consent.
  • Patients who are affiliated to or beneficiaries of a social security scheme.
  • Inclusion criteria specific to the Patient Group:
  • Patients with a personal history of provoked venous thromboembolism, venous thrombosis and/or pulmonary embolism, with the last attack dating back to more than 6 months, and whose clinical phenotype did not justify long-term antithrombotic drug prophylaxis.
  • Definition of provoked venous thromboembolism : The clinical criteria used to classify venous thromboembolism as provoked are :
  • First year of combined oestrogen-progestogen oral contraception, or contraception using an oestrogen-impregnated vaginal ring or transcutaneous synthetic oestrogen patch.
  • Hormonal stimulation for oocyte retrieval
  • Pregnancy and 6 weeks post-partum
  • Surgery
  • Trauma
  • Immobilisation in plaster or splint
  • Outbreak of acute infectious disease
  • Acute flare-up of inflammatory disease
  • Prolonged air travel lasting at least 4 hours
  • Prolonged strict bed rest lasting at least 3 consecutive days.
  • Inclusion criteria specific to the Control Group:
  • Subjects with no personal history of venous thromboembolism
  • Subjects with no family history of venous thromboembolism in first-degree relatives
  • Subjects of the same sex and age with a tolerance of +/- 5 years in relation to the matched case.
  • Exclusion Criteria:
  • Patients who are physically unable to perform the 60-minute walking test, for any reason, in particular cardiovascular contraindications to exercise (recent acute coronary syndrome unstable angina, rhythm disorders, tight aortic stenosis, cardiac heart failure, acute myocarditis, pericarditis or endocarditis endocarditis, poorly controlled hypertension, pre-stress blood pressure \> 200/110 mmHg, recent stroke or transient ischemic attack).
  • Patients on anticoagulant or antithrombotic treatment, ongoing or discontinued within the last month.
  • Patients treated for pulmonary embolism who remain dyspneic after anticoagulant treatment and requiring a work-up for pulmonary hypertension.
  • Last surgery dating back to less than 3 months.
  • Known chronic morbidities: diabetes mellitus, chronic inflammatory or infectious disease, heart failure, renal insufficiency, hepatic insufficiency or arterial thrombosis dating back to less than 3 months.
  • For women: treatment containing synthetic or natural estrogen, in progress or discontinued for less than a month
  • Pregnancy within the last year.
  • Difficult venous access.
  • Regular practice of an intensive sporting/physical activity, such as running, tennis, cycling etc. of more than 3 hours per week.

Trial Officials

Antonia PEREZ MARTIN, Prof.

Principal Investigator

Nîmes University Hospital

Stéphane FAURE

Principal Investigator

Nîmes University Hospital

About Centre Hospitalier Universitaire De Nīmes

The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0